Komori
Changes in Officers4503Astellas Pharma Inc.Pharmaceuticals

Notice of the Resignation of an Outside Director and the Withdrawal of Certain Proposals to Be Submitted to the 21st Annual General Meeting of Shareholders

Andreas Busch resigned as an outside director effective 29 May 2026. Following his withdrawal as a candidate, the number of director candidates in the election proposal to be submitted to the Annual General Meeting of Shareholders changed from 7 to 6.

Worth reading
57In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
1
People
Wording
Definitive
How definitive the wording is.

Who is moving to which position

Resolved 29 May 2026

Departing officer

1 item
Date of departure29 May 2026
Andreas BuschNext role stated
Former PositionOutside directors
New positionRetirement

“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.

Reason for departure

He indicated that he would withdraw his candidacy for outside director.

Whether the incumbent will remain in office (whether they will retain their position)

Resigned as a director and will not continue in office

Directors after the change10Number
Shareholders’ meeting approvalYes. Proposal No. 1, “Election of 6 Directors (excluding Directors who are Audit and Supervisory Committee Members),” and Proposal No. 2 are to be submitted to the 21st Annual General Meeting of Shareholders scheduled for 19 June 2026.
Reason for change

Andreas Busch, candidate No. 6 for outside director, indicated that he would withdraw his candidacy, resulting in this change.

Who is moving to which position
ItemDetails
Resolution date29 May 2026
Date of departure29 May 2026
Name of departing officerAndreas Busch
Former position of departing officerOutside directors
New position of departing officerRetirement
Reason for departureHe indicated that he would withdraw his candidacy for outside director.
Whether the incumbent will remain in officeResigned as a director and will not continue in office
Reason for changeAndreas Busch, candidate No. 6 for outside director, indicated that he would withdraw his candidacy, resulting in this change.
Number of directors after the change10 in total (7 men and 3 women), including 6 independent outside directors
Subject to Approval by the General Meeting of ShareholdersYes. Proposal No. 1, “Election of 6 Directors (excluding Directors who are Audit and Supervisory Committee Members),” and Proposal No. 2 are to be submitted to the 21st Annual General Meeting of Shareholders scheduled for 19 June 2026.
Items this document does not state (11)
Scheduled Appointment DateName of appointeeAppointee's new positionAppointee's previous positionAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeReasons for appointmentFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Andreas Busch, a candidate for outside director, indicated that he would withdraw his candidacy. Following his resignation, the number of directors remains in compliance with the number prescribed by applicable laws and the Articles of Incorporation.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of the Resignation of an Outside Director and the Withdrawal of Certain Proposals to Be Submitted to the 21st Annual General Meeting of Shareholders | Astellas Pharma Inc. (4503) timely disclosure | Komori